Jean-Pierre Sommadossi
President, CEO, and Chairman at Atea Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Atea Pharmaceuticals Inc., 3 years.
Atea Pharmaceuticals Inc.
Director · President, CEO, and Chairman
Chief executive roles
Atea Pharmaceuticals Inc.
· President, CEO, and Chairman
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 31, 2025 | Atea Pharmaceuticals Inc. | Option exercise | +173,467 | — | — |
| Jan 31, 2025 | Atea Pharmaceuticals Inc. | Grant or award | +99,517 | — | — |
| Jan 31, 2025 | Atea Pharmaceuticals Inc. | Shares withheld for tax | −88,601 | $3.06 | $271,119 |
| Sep 19, 2024 | Atea Pharmaceuticals Inc. | Open-market sale | −1,841 | $4.00 | $7,364 |
| Sep 18, 2024 | Atea Pharmaceuticals Inc. | Open-market sale | −22,187 | $4.03 | $89,414 |
| Sep 17, 2024 | Atea Pharmaceuticals Inc. | Open-market sale | −33,941 | $4.05 | $137,461 |
| Jun 5, 2024 | Atea Pharmaceuticals Inc. | Open-market sale | −1,006 | $4.00 | $4,024 |
| Feb 1, 2024 | Atea Pharmaceuticals Inc. | Open-market sale | −56,910 | $3.85 | $219,104 |
| Jan 31, 2024 | Atea Pharmaceuticals Inc. | Option exercise | +173,467 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.